Access Statistics for Don Husereau

Author contact details at EconPapers.

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development 0 0 0 1 0 0 0 7
Capturing Value from Health Technologies in Lean Times 0 0 0 7 1 1 2 65
Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses” 0 0 0 0 1 1 4 4
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement 0 0 0 3 0 0 1 68
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement 0 0 0 7 0 0 0 108
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations 0 0 0 0 0 2 4 4
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations 0 0 0 1 3 3 4 11
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations 0 0 0 1 0 0 2 12
Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations 0 0 0 1 1 1 1 3
Economic evaluations of eHealth technologies: A systematic review 0 0 0 4 0 0 2 15
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists 0 0 2 4 0 2 5 29
How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States? 0 0 1 4 1 1 4 40
Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment 0 0 2 8 0 0 3 50
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis 0 0 0 0 0 0 0 5
Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching 0 0 0 2 0 1 1 20
Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration 0 0 0 0 0 0 0 11
Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline 0 0 0 0 0 1 2 2
Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists 0 0 0 5 1 2 3 59
Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB) 0 0 0 1 0 1 4 10
Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT) 0 0 0 0 0 0 0 5
Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation 0 0 0 6 0 0 0 62
Total Journal Articles 0 0 5 55 8 16 42 590


Statistics updated 2025-03-03